IL2 and COVID-19: Other studies describe an increase in IFN-γ and IL-2 secretion in the unvaccinated pediatric population after symptomatic COVID-19 (41, 42), but a reduction in children with MIS-C (42), yet all our breakthrough cases presented mild COVID-19.